Robust dose-painting-by-numbers vs. nonselective dose escalation for non-small cell lung cancer patients

Steven F. Petit*, Sebastiaan Breedveld, Jan Unkelbach, Dick den Hertog, Marleen Balvert

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
21 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Robust dose-painting-by-numbers vs. nonselective dose escalation for non-small cell lung cancer patients'. Together they form a unique fingerprint.

Nursing and Health Professions

Medicine and Dentistry

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology